Gilead Sciences Aktie

Gilead Sciences für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 885823 / ISIN: US3755581036

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
23.03.2016 17:45:00

Moody's: Hepatitis-C patent ruling negative for Gilead

New York, March 23, 2016 -- Moody's Investors Service commented that a recent jury decision in favor of Merck & Co., Inc. (A1 stable) and against Gilead Sciences, Inc. (A3 positive) related to hepatitis-C patents is credit negative for Gilead. There is currently no impact on Gilead's A3 rating or positive rating outlook.

Vollständigen Artikel bei Moodys lesen